Cointime

Sequentify

company

About

Sequentify develops sample processing technologies and solutions for next-generation sequencing, genomic diagnostics, and therapeutics.

  • 1 - 10

Highlights

Total Funding Amount
$7M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Seed
Last Funding Money Raised
$7M
Industries
Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active

Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications such as cancer diagnostics, carrier screening, COVID-19 surveillance and other applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$7M
Sequentify has raised a total of $7M in funding over 2 rounds. Their latest funding was raised on Oct 31, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 31, 2022 Grant — 1 National Institutes of Health — Detail
May 10, 2022 Seed $7M 1 OurCrowd — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Sequentify is funded by 2 investors. National Institutes of Health and OurCrowd are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
OurCrowd Yes Seed
Cointime
เนื้อหา
บริษัท